Report cover image

Global Cardiovascular Therapeutics Market 2025-2029

Publisher TechNavio
Published Mar 22, 2025
Length 219 Pages
SKU # INF19892318

Description

Cardiovascular Therapeutics Market 2025-2029

The cardiovascular therapeutics market is forecasted to grow by USD 25.32 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the cardiovascular therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing risk factors for cardiovascular diseases, availability of advanced diagnostic methods, and rising prevalence of hypercholesterolemia.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cardiovascular therapeutics market is segmented as below:

By Distribution Channel
  • Hospital pharmacy
  • Retail Pharmacy
  • Online pharmacy
By Type
  • Antithrombotic drugs
  • Hypolipidemic drugs
  • Others
By Route Of Administration
  • Oral
  • Injectable
  • Transdermal
By Geographical Landscape
  • Asia
  • North America
  • Europe
  • Rest of World (ROW)
This study identifies the advent of novel oral anticoagulants (NOACs) as one of the prime reasons driving the cardiovascular therapeutics market growth during the next few years. Also, identification of new pathogenic targets related to cardiovascular diseases and strong incidence of coronary heart disease (CHD) worldwide will lead to sizable demand in the market.

The report on the cardiovascular therapeutics market covers the following areas:
  • Cardiovascular Therapeutics Market sizing
  • Cardiovascular Therapeutics Market forecast
  • Cardiovascular Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiovascular therapeutics market vendors that include Abbott Laboratories, Acutus Medical Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., DR Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the cardiovascular therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

219 Pages
    • Market overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Criticality of inputs and Factors of differentiation
    • Factors of disruption
    • Impact of drivers and challenges
    • Market ecosystem
    • Market characteristics
    • Value chain analysis
    • Market definition
    • Market segment analysis
    • Market size 2024
    • Market outlook: Forecast for 2024-2029
    • Global Cardiovascular Therapeutics Market 2019 - 2023
    • Distribution Channel segment analysis 2019 - 2023
    • Type segment analysis 2019 - 2023
    • Route of Administration segment analysis 2019 - 2023
    • Geography segment analysis 2019 - 2023
    • Country segment analysis 2019 - 2023
    • The AI impact on Global Cardiovascular Therapeutics Market
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
    • Market segments
    • Comparison by Distribution Channel
    • Hospital pharmacy - Market size and forecast 2024-2029
    • Retail Pharmacy - Market size and forecast 2024-2029
    • Online pharmacy - Market size and forecast 2024-2029
    • Market opportunity by Distribution Channel
    • Market segments
    • Comparison by Type
    • Antithrombotic drugs - Market size and forecast 2024-2029
    • Hypolipidemic drugs - Market size and forecast 2024-2029
    • Others - Market size and forecast 2024-2029
    • Market opportunity by Type
    • Market segments
    • Comparison by Route of Administration
    • Oral - Market size and forecast 2024-2029
    • Injectable - Market size and forecast 2024-2029
    • Transdermal - Market size and forecast 2024-2029
    • Market opportunity by Route of Administration
    • Customer landscape overview
    • Geographic segmentation
    • Geographic comparison
    • Asia - Market size and forecast 2024-2029
    • North America - Market size and forecast 2024-2029
    • Europe - Market size and forecast 2024-2029
    • Rest of World (ROW) - Market size and forecast 2024-2029
    • US - Market size and forecast 2024-2029
    • China - Market size and forecast 2024-2029
    • Japan - Market size and forecast 2024-2029
    • India - Market size and forecast 2024-2029
    • South Korea - Market size and forecast 2024-2029
    • Canada - Market size and forecast 2024-2029
    • UK - Market size and forecast 2024-2029
    • Germany - Market size and forecast 2024-2029
    • France - Market size and forecast 2024-2029
    • Italy - Market size and forecast 2024-2029
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Impact of drivers and challenges
    • Market opportunities/restraints
    • Overview
    • Competitive Landscape
    • Landscape disruption
    • Industry risks
    • Companies profiled
    • Company ranking index
    • Market positioning of companies
    • Abbott Laboratories
    • Astellas Pharma Inc.
    • AstraZeneca Plc
    • Aurobindo Pharma Ltd.
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol Myers Squibb Co.
    • Daiichi Sankyo Co. Ltd.
    • Dr Reddys Laboratories Ltd.
    • Eli Lilly and Co.
    • GlaxoSmithKline Plc
    • Johnson and Johnson Services Inc.
    • Merck and Co. Inc.
    • Pfizer Inc.
    • Viatris Inc.
    • Scope of the report
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • Data procurement
    • Data validation
    • Validation techniques employed for market sizing
    • Data synthesis
    • 360 degree market analysis
    • List of abbreviations

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us